Overview
Primary glioblastoma multiforme (GBM) of the cerebellum is a rare and aggressive form of brain cancer characterized by rapid growth and poor prognosis due to its deep location and critical functional areas it affects 1.Diagnosis
Imaging studies (MRI with contrast) essential for diagnosis, highlighting mass effect and enhancement patterns 1.
Histopathological confirmation via stereotactic biopsy necessary to confirm diagnosis and grade tumor 1.
Grading typically follows the WHO classification, with GBM being grade IV 1.Management
First-line treatment: Stereotactic radiosurgery (e.g., Linac-based systems) can be considered for selected cases, especially in interdisciplinary settings 1.
Adjunctive treatments: May include surgical resection, embolization, and conventional radiotherapy, tailored based on multidisciplinary team evaluation 1.
Chemotherapy: No specific drug classes or doses mentioned for cerebellar GBM in the provided abstracts 1.Special Populations
Pediatrics: Not addressed in the provided abstracts 1.
Elderly: No specific considerations noted for elderly patients in the context provided 1.
Comorbidities: Management approach may adapt based on patient comorbidities, though specific guidance not detailed in the abstracts 1.Key Recommendations
Utilize interdisciplinary approaches for diagnosis and treatment planning in cerebellar GBM to facilitate multimodal therapy options (Evidence: Expert opinion 1).
Consider stereotactic radiosurgery as a viable treatment modality, particularly in specialized centers with appropriate equipment and expertise (Evidence: Weak 1).
Histopathological confirmation via stereotactic biopsy is crucial for accurate diagnosis and grading of cerebellar GBM (Evidence: Moderate 1).References
1 Duffner F, Becker G, Boldt R, Voigt K, Klier R, Bamberg M et al.. Five years of stereotactic radiosurgery at the University of Tübingen--a critical review of the method. Minimally invasive neurosurgery : MIN 1997. link